Drug Pipeline

Rucaparib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03768063 A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd… Cancer Active, Not Recruiting
Phase 2
NCT03899155 Pan Tumor Rollover Study Cancer Recruiting
NCT02873962 A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib Peritoneal Cancer Active, Not Recruiting
Sponsors Running Rucaparib Trials
Dana-Farber Cancer Institute (1) Hoffmann-La Roche (1) Bristol-Myers Squibb (1)
Disease Areas
Ovarian Cancer (1)
Get alerts when Rucaparib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free